Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 7 of 7)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
24-Apr-14ValuEngine, Inc.N/AValuEngine - Toronto Quantitative Stock Report for COM11$25  View Abstract
23-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - CARDIOME PHARMA CORP. (COM-T)11$25  View Abstract
22-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Cardiome Pharma Corp.42$75  View Abstract
19-Apr-14Reuters Investment ProfileN/ACardiome Pharma Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
10-Apr-14GlobalDataGlobalDataCardiome Pharma Corp (COM) - Financial and Strategic SWOT Analysis Review42$125  View Abstract
27-Mar-14GlobalDataGlobalDataCardiome Pharma Corp (COM) - Financial and Strategic SWOT Analysis Review41$125  View Abstract
27-Mar-14Thomson Reuters StreetEventsResearch DepartmentCOM.TO - Event Transcript of Cardiome Pharma Corp conference call, Mar. 27, 2014 / 8:00AM ET15$75  View Abstract

Independent Reports (Showing 1 to 7 of 7)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
24-Apr-14ValuEngine, Inc.N/AValuEngine - Toronto Quantitative Stock Report for COM11$25View Abstract
23-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - CARDIOME PHARMA CORP. (COM-T)11$25View Abstract
22-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Cardiome Pharma Corp.42$75View Abstract
19-Apr-14Reuters Investment ProfileN/ACardiome Pharma Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
10-Apr-14GlobalDataGlobalDataCardiome Pharma Corp (COM) - Financial and Strategic SWOT Analysis Review42$125View Abstract
27-Mar-14GlobalDataGlobalDataCardiome Pharma Corp (COM) - Financial and Strategic SWOT Analysis Review41$125View Abstract
27-Mar-14Thomson Reuters StreetEventsResearch DepartmentCOM.TO - Event Transcript of Cardiome Pharma Corp conference call, Mar. 27, 2014 / 8:00AM ET15$75View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.